-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The discovery of enzymatic RNA molecules, termed ribozymes (
1
,
2
), fundamentally changed our view of the function of RNA in chemistry, biology, and medicine. Naturally occurring enzymatic RNA molecules catalyze sequence-specific RNA processing. The sequence specificity is determined by the ability of the ribozyme to base pair with nucleotides near the cleavage site of the target RNA; by altering the substrate recognition sequences, intramolecular,
cis
-cleaving ribozymes can be engineered to cleave in
trans
(reviewed in Cech, T. R., [
3
]). In theory, ribozymes can be engineered to cleave any RNA species, site-specifically, in the background of cellular RNA. This cleavage event renders the target mRNA unstable and abrogates protein expression.